JP Morgan Chase
INBX icon

JP Morgan Chase’s Inhibrx INBX Stock Holding History

JP Morgan Chase’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Buy
5,260
+328
+7% +$32.9K ﹤0.01% 5132
2026
Q1 		$295K Sell
4,932
-12,127
-71% -$900K ﹤0.01% 5289
2025
Q4 		$1.35M Buy
17,059
+12,230
+253% +$833K ﹤0.01% 4401
2025
Q3 		$163K Sell
4,829
-479
-9% -$11.8K ﹤0.01% 5627
2025
Q2 		$75.7K Sell
5,308
-1,089
-17% -$14.1K ﹤0.01% 5731
2025
Q1 		$89.5K Sell
6,397
-1,195
-16% -$16.2K ﹤0.01% 5626
2024
Q4 		$117K Buy
7,592
+2,457
+48% +$37.4K ﹤0.01% 5695
2024
Q3 		$80.4K Sell
5,135
-39,130
-88% -$550K ﹤0.01% 5790
2024
Q2 		$627K Buy
+44,265
New +$691K ﹤0.01% 4556

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase's INBX Position: Q2 2026 in Review

JP Morgan Chase increased its Inhibrx (INBX) stake by 6.7% in Q2 2026, buying an estimated $32.9K and bringing the position to 5,260 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #5132.

JP Morgan Chase first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.35M in Q4 2025. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • JP Morgan Chase held 5,260 shares of Inhibrx worth $502K as of Q2 2026.
  • JP Morgan Chase bought 328 Inhibrx shares in Q2 2026, an estimated $32.9K.
  • Inhibrx made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5132 holding.
  • JP Morgan Chase first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • JP Morgan Chase's Inhibrx position peaked at $1.35M in Q4 2025.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.